An investigation of the relationship between Ipo underpricing and Esg score in the healthcare industry

Abstract

This investigation aims to explore the correlation between companies' ESG score and their underpricing at IPO, with a focus on the healthcare sector. Using regression analysis and considering several control variables associated with underpricing, it was found that ESG score can significantly influence underpricing: the results obtained from the study suggest that there is a positive relationship between the two variables, indicating that companies that invest in ESG tend to have higher levels of underpricing than others.